Although FBS illustrated no significant difference between the controls and patients with UC and CD, insulin and homeostatic model assessment for insulin resistance (HOMA-IR) were dramatically higher in the CD patients compared to the controls. The gene discussed is INS; the disease is Insulin resistance.